Cargando…
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer
Vaccines to combat SARS-CoV-2 infection and the COVID-19 pandemic were quickly developed due to significant and combined efforts by the scientific community, government agencies, and private sector pharmaceutical and biotechnology companies. Following vaccine development, which took less than a year...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133965/ https://www.ncbi.nlm.nih.gov/pubmed/36210565 http://dx.doi.org/10.1016/j.thromres.2022.02.009 |